Asset Details
Do you wish to reserve the book?
Is hydroxychloroquine beneficial for COVID-19 patients?
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Is hydroxychloroquine beneficial for COVID-19 patients?
Do you wish to request the book?
Is hydroxychloroquine beneficial for COVID-19 patients?
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Is hydroxychloroquine beneficial for COVID-19 patients?
2020
Overview
The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in December 2019. As similar cases rapidly emerged around the world
1
,
2
–
3
, the World Health Organization (WHO) declared a public health emergency of international concern on January 30, 2020 and pronounced the rapidly spreading coronavirus outbreak as a pandemic on March 11, 2020
4
. The virus has reached almost all countries of the globe. As of June 3, 2020, the accumulated confirmed cases reached 6,479,405 with more than 383,013 deaths worldwide. The urgent and emergency care of COVID-19 patients calls for effective drugs, in addition to the beneficial effects of remdesivir
5
, to control the disease and halt the pandemic.
Publisher
Nature Publishing Group UK,Springer Nature B.V
Subject
/ 96/21
/ 96/95
/ Adenosine Monophosphate - analogs & derivatives
/ Adenosine Monophosphate - therapeutic use
/ Alanine - analogs & derivatives
/ Anti-Inflammatory Agents - therapeutic use
/ Antigens
/ Antiviral Agents - therapeutic use
/ Betacoronavirus - drug effects
/ Biomedical and Life Sciences
/ Chloroquine - therapeutic use
/ Coronavirus Infections - drug therapy
/ COVID-19
/ Drugs
/ Humans
/ Hydroxychloroquine - therapeutic use
/ Lupus
/ Malaria
/ Pneumonia, Viral - drug therapy
/ Risk
/ Severe acute respiratory syndrome coronavirus 2
/ Viruses
